Clinical Trials Logo

Infertility clinical trials

View clinical trials related to Infertility.

Filter by:

NCT ID: NCT01599494 Withdrawn - Infertility Clinical Trials

An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

Start date: March 2014
Phase: Phase 3
Study type: Interventional

This study, conducted in India, will be recruiting women participants who are between the ages of 18 and 42, and who have an indication for controlled ovarian stimulation (COS), but have not yet undergone in-vitro fertilization and/or intracytoplasmic sperm injection (IVF/ICSI). The study is designed to compare the difference in oocyte (immature egg cell) production after administration of the investigative drug, MK-8962 (corifollitropin alfa) + recombinant follicle stimulating hormone (recFSH), in contrast to use of only the reference drug, recFSH.

NCT ID: NCT01594645 Withdrawn - Infertility Clinical Trials

The Clinical Impact of Selecting Acrosome Reacted Spermatozoa for ICSI

Start date: September 2012
Phase: Phase 1
Study type: Interventional

Presently spermatozoa for ICSI are selected based on morphology and motion, without determining if acrosome reaction (AR) had occurred during sperm preparation or not. Although not critical if the sperm is injected into the ooplasm, the occurrence of AR might might be an indicator of better spermatozoon quality and implantation potential, especially in severe OTA cases. It is impossible with conventional plain optic microscopy used in IVF units to determine in vivo (without fixation) if AR has occurred, and as a result spermatozoa are injected randomly. It is readily possible to distinguish AR+ from AR- spermatozoa using polarized light microscopy due to different bifriengance. In this study the investigators seek to determine, by a prospective RCT, if selecting only acrosome reacted spermatozoa, in severe OTA cases, will improve the outcome of ICSI and the entire IVF process.

NCT ID: NCT01577199 Withdrawn - Infertility Clinical Trials

RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders

CLOVANT
Start date: April 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is compare two commonly-used medication protocols ( low-dose clomiphene citrate and high dose gonadotropin protocols) for the treatment of patients with diminished ovarian reserve (decreased number of eggs remaining in the ovary) undergoing IVF. This research is being done because we do not know if these two medication protocols are equally likely to help a woman become pregnant.

NCT ID: NCT01346631 Withdrawn - Male Infertility Clinical Trials

The Paleolithic Diet and Male Factor Infertility

Start date: May 2011
Phase: N/A
Study type: Interventional

Prospective studies concerning diet and male fertility are lacking. Observational studies suggest that a diet rich in fruits, vegetables and meats may be associated with higher sperm counts. The investigators wanted to see if a "paleolithic diet" consisting of meat, fish, fruits vegetables and nuts and lacking grains, legumes and dairy products can improve sperm counts.

NCT ID: NCT01294904 Withdrawn - Infertility Clinical Trials

Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney Disease

Start date: January 2011
Phase:
Study type: Observational

Patients with chronic kidney disease (both men and women), especially those with terminal renal failure, manifest infertility. There has been demonstrated several hormonal changes in patients on dialysis. Increased levels of luteinizing hormone (LH) has been seen in men (12). In women the opposite has been reported. The number of spermatocytes is reduced and a disturbance in maturation has been observed. This project is aimed to study the influence of uremic milieu on fertility in men and women. The hypopituitary/hypothalamus gland axis and hormonal levels will be studied.

NCT ID: NCT01267604 Withdrawn - Infertility Clinical Trials

Ovarian Stimulation: Inositol and Melatonin

Start date: December 2010
Phase: Phase 4
Study type: Interventional

An efficient protocol of ovarian stimulation is a key part of assisted reproductive technology. In order to obtain the highest oocyte retrieval with no adverse effects, numerous studies have evaluated the efficiency of the clinical approaches currently available. Recent studies have shown that two natural compounds, such as inositol and melatonin, play an important role in oocyte maturation and quality. Therefore, the present study aims at investigating whether inositol and melatonin are able to improve the number of oocytes obtained after ovarian stimulation with Recombinant Follicle Stimulating Hormone (rFSH). To this purpose, a randomized double-blind trial will be established where 150 healthy women in reproductive age undergoing to assistant reproductive technology (ART) because of male infertility will be divided in two groups. Group A will be treated with 225IU rFSH alone, group B will be treated with 225IU rFSH, 4g inositol and 3mg melatonin. As primary outcome of the study, oocyte quality, total number of oocytes retrieved, clinical pregnancy rate and live birth rate will be evaluated in group A vs. group B.

NCT ID: NCT01156324 Withdrawn - Infertility Clinical Trials

The Impact of an Online Stress Management Program on In Vitro Fertilization (IVF) Outcome

Start date: July 2010
Phase: N/A
Study type: Interventional

The goal of this study is to determine the impact of an online stress management program, which combines stress reduction and prevention strategies with personal care products/rituals which have relaxation properties, on pregnancy rates and psychological distress in women undergoing IVF for the first time.

NCT ID: NCT01033474 Withdrawn - Infertility Clinical Trials

Results Following the Vitrification of Human Oocytes Using 2 Methodologies

Start date: December 2009
Phase: N/A
Study type: Observational

The investigators are going to compare embryo developmental rates of human eggs following freezing in two different freezing methods. The investigators are going to compare the pregnancy rates following transfer to patients as well. Null Hypothesis: The type of vitrification methodology used will not have an impact on the following: - Survival rates - Embryonic developmental rates - Pregnancy and implantation rates.

NCT ID: NCT00826839 Withdrawn - Infertility Clinical Trials

Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients

OMLET
Start date: January 2009
Phase: Phase 4
Study type: Interventional

Hundreds of thousands of couples in the United States experience infertility each year. When initial measures do not help, some couples require a process called ovarian stimulation and in vitro fertilization (IVF). Usually, a woman produces at most one egg each month. Ovarian stimulation helps these women make more than one egg per month. However, this involves taking hormones that stimulate the ovary to produce many eggs at one time. The stimulatory hormones injected with a small needle. The eggs are removed from the ovary through a surgical procedure and then placed in a dish for fertilization by sperm to form embryos. The embryos are grown in the laboratory then replaced into the woman's uterus 3-5 days later. The stimulation of the ovaries is important. Some patients undergo ovarian stimulation for IVF but do not respond to the treatment. This is a very difficult situation because even though several ovarian stimulation protocols have been used for poor responder patients, it is not clear which protocol works best. In fact, two of the most commonly used protocols have not been directly compared. This study will randomize (like flipping a coin) couples with a history of low response who are going to start IVF treatment into two groups. In one group the female partner will use a protocol called "E2 patch/antagonist". These women will use an estrogen patch and injected antagonist for several days before starting injectable fertility medications. The other group will use a protocol called "OCP/microdose". This group of women will use oral contraceptive pills (OCPs) and small doses of lupron along with the other injectable fertility medications. We will then follow their progress to see how many eggs they produce and how many women get pregnant.

NCT ID: NCT00814437 Withdrawn - Infertility Clinical Trials

Physiological Role of KiSS-1/GPR54 System in the Human Ovary

001-KIS
Start date: April 2009
Phase: N/A
Study type: Observational

The aim of this project is to study the physiological role of the KiSS-1/GPR54 system in the granulosa cells of the human ovary.